BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) for UNIVERSITY OF UTAH--ARUP LABORATORIES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Yet to be introduced, and unnumbered, legislation modernizing the regulation and oversight of Lab Developed Tests. Issues associated with the draft guidance released by the FDA regarding the regulation of Laboratory Developed Tests (LDT's). Issues in the Congress generally associated with Laboratory Developed Tests and potential FDA Regulation of such tests. PAMA passage and implementation--issues associated with LDT's. Pharmacogenetic issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES C BARKER | — |
| NICHOLAS CROCKETT | — |
Budget/Appropriations BUD
The FY2020 Budget, provisions dealing with Health Care, Medicare reimbursement issues, and Laboratory Developed Tests Related Issues. FY2020 Agriculture Appropriations Bills provisions relating to the FDA and LDT's. The FY2020 Labor, HHS Appropriations Bills provisions related to PAMA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES C BARKER | — |
| NICHOLAS CROCKETT | — |
Medicare/Medicaid MMM
Clinical Laboratory Related Issues, Physician Fee Schedule, Laboratory Test Fees, Federal issues associated with modifying the Lab Fee Schedule. Federal issues associated with Laboratory Developed Tests and issues associated with the FDA regulation of LDT's. Yet unnumbered Federal legislation dealing with LDT's. PAMA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES C BARKER | — |
| NICHOLAS CROCKETT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.